Genta to Address Year End Financial 2002 Results and Progress In Conference Call and Webcast
BERKELEY HEIGHTS, N.J., Feb. 6 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq:GNTA) announced it will hold a conference call and live audio webcast to discuss its fourth quarter 2002 financial results on Thursday, February 13, 2003. Dr. Raymond P. Warrell, Jr., Genta's Chief Executive Officer, and other corporate officers will host the conference call and live audio webcast at 7:30 AM EST to discuss the 2002 financial results and corporate progress.
The conference call can be accessed by dialing:
Within the U.S.: 1-888-529-1867
Outside the U.S. 1-706-643-1282
The webcast can be accessed through the Investor Relations section of the Company's website at: genta.com . A replay of the webcast will be available for 90 days following the presentation.
About Genta
Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on anticancer therapy. The Company's research platform is anchored by oligonucleotide chemistry, particularly applications of antisense and decoy aptamer technology. GenasenseTM, the Company's lead compound, is being developed in collaboration with Aventis and is currently undergoing late-stage, Phase 3 clinical testing in several clinical indications. Genta's pipeline also comprises a portfolio of small molecules, including gallium-containing compounds and Androgenics compounds for prostate cancer, as well as an anticancer series of DNA-based compounds called "decoy aptamers". For more information about Genta, please visit our website at: genta.com .
This press release and the webcast to follow contain forward-looking statements with respect to business conducted by Genta Incorporated. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially. For a discussion of those risks and uncertainties, please see the Company's Annual Report/Form 10-K for 2001.
SOURCE Genta Incorporated
CO: Genta Incorporated
ST: New Jersey
SU: CCA
prnewswire.com
02/06/2003 14:23 EST |
